RECURSION PHARMACEUTICALS, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
RECURSION PHARMACEUTICALS, INC. (RXRX) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $17.18 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-05
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $17.18M.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $18.69M.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $20.21M.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $21.73M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $17.18M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $18.69M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $20.21M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $21.73M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $23.24M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $24.76M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $26.27M 10-K · filed 2026-02-25 |
| 2024-09-30 | $26.90M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $28.56M 10-Q · filed 2024-08-08 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |